Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 414-420 , September 2010

Status epilepticus alters hippocampal PKAβ and PKAγ expression in mice

  • Jian Xin Liu

      Affiliations

    • Institute of Neurobiology, School of Medicine, Xi’an Jiaotong University, Xi’an, PR China
    • Temasek Laboratories, National University of Singapore, Singapore
  • ,
  • Yong Cheng Tang

      Affiliations

    • Temasek Laboratories, National University of Singapore, Singapore
  • ,
  • Yong Liu

      Affiliations

    • Institute of Neurobiology, School of Medicine, Xi’an Jiaotong University, Xi’an, PR China
  • ,
  • Feng Ru Tang

      Affiliations

    • Temasek Laboratories, National University of Singapore, Singapore
    • Department of Anatomy, National University of Singapore, Singapore
    • Corresponding Author InformationCorresponding author at: Temasek Laboratories, National University of Singapore, 5A Engineering Drive 1, #06-27, Singapore 117411, Singapore. Tel.: +65 66011094; fax: +65 68726840.

Received 9 September 2009 ,Revised 12 June 2010 ,Accepted 17 June 2010.

  • Image Result

    Immunocytochemical staining shows cPKAβ (A) and cPKAγ (B) immunopositive product in the hippocampus of the control mice. Moderate cPKAβ immunopositive product is localized in the stratum pyramidale (S

    Immunocytochemical staining shows cPKAβ (A) and cPKAγ (B) immunopositive product in the hippocampus of the control mice. Moderate cPKAβ immunopositive product is localized in the stratum pyramidale (SP) of CA1-3 areas and in the stratum granulosum (SG) of the dentate gyrus. Weak cPKAβ immunopositive product is located in the stratum lucidum of CA3 area (arrows). Moderately to strongly stained cPKAγ (B) immunopositive product is localized in the hilus and molecular layer (asterisks) of the dentate gyrus and in the stratum lucidum (arrows) of CA3 area. Scale bar=200μm, also applies to (A).

  • Image Result
    cPKAβ (A–D) immunopositive product in the stratum pyramiale of the CA1 area decreases significantly at 30min (B) and 2h during pilocarpine induced status epilepticus (C) compared to the control (A), b

    cPKAβ (A–D) immunopositive product in the stratum pyramiale of the CA1 area decreases significantly at 30min (B) and 2h during pilocarpine induced status epilepticus (C) compared to the control (A), but returns back at 1 day after pilocarpine induced status epilepticus (D). In different strata of CA1 area, the number of cPKAβ immunopositive neurons decreases at 30min (B) and 2h during pilocarpine induced status epilepticus (C), while the number of cPKAγ (E–H) immunopositive neurons decreases at 30min (F), 2h during (G) and 1 day after (H) pilocarpine induced status epilepticus compared to the control (E). (H) Scale bar=100μm, also applies to (A–G).

  • Image Result
    The number of cPKAβ (A–D) and cPKAγ (E–H) immunopositive neurons decreases progressively in the hilus of the dentate gyrus from 30min during (cPKAβ: B; cPKAγ: F) to 1 day after (cPKAβ: D; cPKAγ: H) pi

    The number of cPKAβ (A–D) and cPKAγ (E–H) immunopositive neurons decreases progressively in the hilus of the dentate gyrus from 30min during (cPKAβ: B; cPKAγ: F) to 1 day after (cPKAβ: D; cPKAγ: H) pilocarpine induced status epilepticus. (H) Scale bar=200μm, also applies to (A–G).

  • Image Result
    Histograms showing the progressive changes of cPKAβ or cPKAγ immunopositive neurons/product within 1 day during and after pilocarpine induced status epilepticus. n=18 observations from 6 rats. *p<0

    Histograms showing the progressive changes of cPKAβ or cPKAγ immunopositive neurons/product within 1 day during and after pilocarpine induced status epilepticus. n=18 observations from 6 rats. *p<0.01, +p<0.05 compared with the control. Cell density is indicated as a number per square millimeter; intensity of immunpositive product is indicated as a grey value. Note that the increase of intensity (grey value) indicates the decrease of protein expression, the two are negatively coupled.

  • Image Result
    Double-labeling immunofluoresence microscopy shows co-localization (yellow, arrows) of cPKAβ (A–C, red) or cPKAγ (D–F, red) with CB (A, D, green), CR (B, E, green) or PV (C, F, green) in CA1 area of t

    Double-labeling immunofluoresence microscopy shows co-localization (yellow, arrows) of cPKAβ (A–C, red) or cPKAγ (D–F, red) with CB (A, D, green), CR (B, E, green) or PV (C, F, green) in CA1 area of the hippocampus of the control mouse. In the hilus of the dentate gyrus, co-localization (yellow, arrows) of cPKAβ (G–I, red) or cPKAγ (J–L, red) with CB (G, J, green), CR (H, K, green) or PV (I, L, green) is also indicated. Note that there is not co-localization of cPKA with CB (G–J, green) in hilar neurons. (F) Scale bar=100μm, also applies to (A–E); (L) scale bar=100μm, also applies to (G–K). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)

 Supported by research grant (No: NMRC/0960/2005) from the National Medical Research Council (NMRC) of Singapore as trainee in Epilepsy Research Lab. This study was supported by NMRC grants (No: NMRC/0960/2005) and Singhealth Research Foundation (Nos: SHF/FG217P/2005 and SHF/FG382P/2007) to FR Tang and Guang Hua medical research grant (0203411) from Xi’an Jiaotong University.

PII: S1059-1311(10)00137-8

doi: 10.1016/j.seizure.2010.06.008

Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 414-420 , September 2010